Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1

Our retrospective study showed inhibition of the renin–angiotensin system was associated with better outcomes in patients with advanced pancreatic cancer receiving gemcitabine. The primary objective of this phase I study was to determine the recommended dose of candesartan in combination with gemcit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Nakai, Yousuke, Isayama, Hiroyuki, Ijichi, Hideaki, Sasaki, Takashi, Kogure, Hirofumi, Yagioka, Hiroshi, Miyabayashi, Koji, Mizuno, Suguru, Yamamoto, Keisuke, Mouri, Dai, Kawakubo, Kazumichi, Yamamoto, Natsuyo, Hirano, Kenji, Sasahira, Naoki, Tateishi, Keisuke, Tada, Minoru, Koike, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659287/
https://ncbi.nlm.nih.gov/pubmed/22515232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02311.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados